News Quantified

Stock Stats

News Stats


All News	{{AllNewsCount}}
News Wires	{{NewsWiresCount}}
Media Monitoring	{{MoreOverCount}}
SEC Edgar Filings	{{SecEdgarFilingsCount}}
Upgrades	{{UpgradesCount}}
Downgrades	{{DowngradesCount}}
Initiated	{{InitiatesCount}}
Reiterated	{{ReiteratesCount}}
Last Earnings	{{LastEarnings}}
Last Earnings EPS	{{LastEps}}
Next Earnings	{{NextEarnings}}

Order Stats

Sub-Penny
{{SubPennyStr}}
Odd Lot
{{OddLotStr}}
Avg. bid-ask spread

{{GetAvgBidAskSpreadForScale}}
Avg. bid / ask size
{{GetAvgBidSizeForScale}} {{GetAvgAskSizeForScale}}

Shares at ask / bid
{{SharesAtAsk_AMP_Str}} {{SharesAtBid_AMP_Str}}
Off exchange
{{OffExchange}}

News

Climb Bio (CLYM) was upgraded by B. Riley Financial, Inc. to "strong-buy".

Climb Bio (CLYM) is now covered by B. Riley Financial, Inc.. They set a "buy" rating and a $26.00 price target on the stock.

Climb Bio (CLYM) was upgraded by Truist Financial Corporation to "strong-buy".

Climb Bio (CLYM) was given a new $17.00 price target by Truist Financial Corporation.

Climb Bio Highlights Budoprutug and CLYM116 Milestones, Sets Up “Rich Data Year” in 2026 [Yahoo! Finance]

Raymond James Financial, Inc.

Form S-8 Climb Bio, Inc.

Form 10-K Climb Bio, Inc. For: Dec 31

Form 8-K Climb Bio, Inc. For: Mar 05

Form 4 Climb Bio, Inc. For: Feb 25 Filed by: Thomas Stephen Basil

Form 144 Climb Bio, Inc. Filed by: Thomas Stephen Basil

52 Week High	{{GetCompanyStockInfo.Week52HighValue}} {{GetCompanyStockInfo.Week52HighDate}}
52 Week Low	{{GetCompanyStockInfo.Week52LowValue}} {{GetCompanyStockInfo.Week52LowDate}}

Today’s Volatility	{{VolatilityStr}}
20 Day Volatility	{{Volatility20Str}}

Open	{{GetCompanyStockInfo.Open}}
Prior Close	{{GetCompanyStockInfo.PriorCloseValue}} {{GetCompanyStockInfo.PriorCloseDate}}